FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164655047> ?p ?o ?g. }

• W2164655047 endingPage "70" @default.
• W2164655047 startingPage "1165" @default.
• W2164655047 abstract "Canine splenic hemangiosarcoma (HSA) is a spontaneous tumor with high metastatic potential. Despite surgical excision, most dogs die within 2 months of diagnosis as a result of widespread visceral metastasis. This study was designed to determine the efficacy of liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE) when used in combination with splenectomy and systemic chemotherapy for the treatment of HSA in the dog. Thirty-two dogs with HSA and without gross evidence of metastases were treated with splenectomy, stratified by clinical stage, and randomized to receive doxorubicin/cyclophosphamide chemotherapy and either L-MTP-PE immunotherapy or lipid equivalent (placebo liposomes). Dogs were subsequently followed to determine disease-free survival and overall survival times. The effects of L-MTP-PE on serum tumor necrosis factor-alpha and interleukin 6 activity were assessed on a small subset of dogs. Dogs receiving L-MTP-PE had significantly prolonged disease-free survival (P = 0.037) and overall survival (P = 0.029) compared with dogs receiving placebo. Dogs with clinical stage I disease had significantly prolonged disease-free survival (P = 0. 026) and overall survival (P = 0.017) compared with dogs with clinical stage II disease. Dogs receiving L-MTP-PE had significantly greater serum tumor necrosis factor-alpha (P < 0.001) and interleukin 6 (P = 0.007) activities compared with placebo-treated dogs. L-MTP-PE has significant antimetastatic activity in highly malignant, spontaneously occurring, splenic HSA in the dog. Canine HSA may have potential as a large animal model for additional investigation of antimetastatic chemoimmunotherapy." @default.
• W2164655047 created "2016-06-24" @default.
• W2164655047 creator A5012901008 @default.
• W2164655047 creator A5021474295 @default.
• W2164655047 creator A5029351012 @default.
• W2164655047 creator A5029701926 @default.
• W2164655047 creator A5038318942 @default.
• W2164655047 creator A5043559536 @default.
• W2164655047 creator A5047472326 @default.
• W2164655047 creator A5052093839 @default.
• W2164655047 creator A5063338284 @default.
• W2164655047 creator A5072414918 @default.
• W2164655047 date "1995-10-01" @default.
• W2164655047 modified "2023-10-16" @default.
• W2164655047 title "Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial." @default.
• W2164655047 cites W1488949116 @default.
• W2164655047 cites W1502940583 @default.
• W2164655047 cites W1522954686 @default.
• W2164655047 cites W1576365704 @default.
• W2164655047 cites W1580788756 @default.
• W2164655047 cites W1747714045 @default.
• W2164655047 cites W1815665069 @default.
• W2164655047 cites W1853090251 @default.
• W2164655047 cites W1965608693 @default.
• W2164655047 cites W1979724799 @default.
• W2164655047 cites W1981376615 @default.
• W2164655047 cites W2058106429 @default.
• W2164655047 cites W2061315324 @default.
• W2164655047 cites W2077972669 @default.
• W2164655047 cites W2094338250 @default.
• W2164655047 cites W2104729679 @default.
• W2164655047 cites W2137678925 @default.
• W2164655047 cites W2236630874 @default.
• W2164655047 cites W2258560878 @default.
• W2164655047 cites W2265845847 @default.
• W2164655047 cites W2412190227 @default.
• W2164655047 cites W2413983019 @default.
• W2164655047 cites W2467284080 @default.
• W2164655047 cites W76913732 @default.
• W2164655047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9815908" @default.
• W2164655047 hasPublicationYear "1995" @default.
• W2164655047 type Work @default.
• W2164655047 sameAs 2164655047 @default.
• W2164655047 citedByCount "36" @default.
• W2164655047 countsByYear W21646550472012 @default.
• W2164655047 countsByYear W21646550472014 @default.
• W2164655047 countsByYear W21646550472015 @default.
• W2164655047 countsByYear W21646550472016 @default.
• W2164655047 countsByYear W21646550472017 @default.
• W2164655047 countsByYear W21646550472018 @default.
• W2164655047 countsByYear W21646550472019 @default.
• W2164655047 countsByYear W21646550472020 @default.
• W2164655047 countsByYear W21646550472021 @default.
• W2164655047 countsByYear W21646550472022 @default.
• W2164655047 countsByYear W21646550472023 @default.
• W2164655047 crossrefType "journal-article" @default.
• W2164655047 hasAuthorship W2164655047A5012901008 @default.
• W2164655047 hasAuthorship W2164655047A5021474295 @default.
• W2164655047 hasAuthorship W2164655047A5029351012 @default.
• W2164655047 hasAuthorship W2164655047A5029701926 @default.
• W2164655047 hasAuthorship W2164655047A5038318942 @default.
• W2164655047 hasAuthorship W2164655047A5043559536 @default.
• W2164655047 hasAuthorship W2164655047A5047472326 @default.
• W2164655047 hasAuthorship W2164655047A5052093839 @default.
• W2164655047 hasAuthorship W2164655047A5063338284 @default.
• W2164655047 hasAuthorship W2164655047A5072414918 @default.
• W2164655047 hasConcept C126322002 @default.
• W2164655047 hasConcept C141071460 @default.
• W2164655047 hasConcept C142724271 @default.
• W2164655047 hasConcept C203014093 @default.
• W2164655047 hasConcept C2776309230 @default.
• W2164655047 hasConcept C2776694085 @default.
• W2164655047 hasConcept C2776755627 @default.
• W2164655047 hasConcept C2779217266 @default.
• W2164655047 hasConcept C2780790343 @default.
• W2164655047 hasConcept C2780931953 @default.
• W2164655047 hasConcept C2781082889 @default.
• W2164655047 hasConcept C71924100 @default.
• W2164655047 hasConcept C90924648 @default.
• W2164655047 hasConceptScore W2164655047C126322002 @default.
• W2164655047 hasConceptScore W2164655047C141071460 @default.
• W2164655047 hasConceptScore W2164655047C142724271 @default.
• W2164655047 hasConceptScore W2164655047C203014093 @default.
• W2164655047 hasConceptScore W2164655047C2776309230 @default.
• W2164655047 hasConceptScore W2164655047C2776694085 @default.
• W2164655047 hasConceptScore W2164655047C2776755627 @default.
• W2164655047 hasConceptScore W2164655047C2779217266 @default.
• W2164655047 hasConceptScore W2164655047C2780790343 @default.
• W2164655047 hasConceptScore W2164655047C2780931953 @default.
• W2164655047 hasConceptScore W2164655047C2781082889 @default.
• W2164655047 hasConceptScore W2164655047C71924100 @default.
• W2164655047 hasConceptScore W2164655047C90924648 @default.
• W2164655047 hasIssue "10" @default.
• W2164655047 hasLocation W21646550471 @default.
• W2164655047 hasOpenAccess W2164655047 @default.
• W2164655047 hasPrimaryLocation W21646550471 @default.
• W2164655047 hasRelatedWork W1948322631 @default.
• W2164655047 hasRelatedWork W1982869814 @default.

• next